Fluorodeoxyglucose-PET guided biopsy

PET-guided breast biopsy.

Molecular imaging, using positron emission tomography (PET), has become an integral step in the evaluation of many patients with malignancy. However, its use in patients with breast cancer has been limited by the lower levels of (18) F-fluorodeoxyglucose (FDG) uptake in some breast malignancies compared to other cancers, the small size of many breast cancers, and the need for biopsy under PET g...

Lung Lesions Biopsy in Children by Computed Tomography (CT) Fluoroscopy Guided Versus Conventional CT Scan Guided

Abstract Background Computed tomography (CT)-guided biopsy of the lung is a well-established method of diagnosis. The aim of this study was to determine the success rate of fluoroscopic CT (FCT) and conventional CT (CCT) in needle navigation biopsies from the lung lesions. Materials and Methods A total of 78 patients were prospectively enrolled to receive CT-guided biopsy with (group I, n=2...

Visualization of pericarditis by fluorodeoxyglucose PET.

Transthoracic image guided biopsy.

Transthoracic image guided biopsy is now firmly established in the armamentarium of diagnostic tests to establish the nature of a mass in the lung, pleura, mediastinum or chest wall. It may be performed under computed tomographic, ultrasonic or fluoroscopic control, and provided a fine needle technique is employed, morbidity is low. Worldwide reports show a 90% true positive yield and a false p...

PET/CT-guided percutaneous biopsy of isolated intramuscular metastases from postcricoid cancer.

(18)F-FDG PET/CT has made it possible to identify many unsuspected lesions such as isolated intramuscular metastases because of its ability to detect abnormal metabolic activity in an early stage even without clinical symptoms or morphologic changes. We need to modify our routine techniques for performing biopsies of such lesions because they may not be visualized on morphologic imaging. We des...